By analyzing 99 clinical samples and human CRC cell lines, Ogawa et al. found that up-regulated expression of CXCL1 hindering the CXCL1/8-CXCR2 axis may offer a new method for the treatment of SMAD4-negative CRC [43]. This evidence concerns the gene CXCR2 and colorectal carcinoma.